High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE

Clinical Orthopaedics and Related Research

Volumn 470, Issue 5, 2012, Pages 1461-1471

  Singer, Joachim ^a   Merz, Andreas ^a   Frommelt, Lars ^b   Fink, Bernd ^a  

^a Orthopaedic Clinic Markgröningen GGmbH   (Germany)

^b ENDO Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; FLUCLOXACILLIN; GENTAMICIN; LINEZOLID; OFLOXACIN; PENICILLIN G; RIFAMPICIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; INTERMETHOD COMPARISON; JOINT BIOPSY; KNEE PROSTHESIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTHESIS INFECTION; REINFECTION; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; SYNDROME DELINEATION; TOTAL KNEE REPLACEMENT;

EID: 84859839869     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-2174-6     Document Type: Article

References (58)

1. Anagnostakos K, Kelm J, Regitz T, Schmitt E, Jung W. In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers. J Biomed Mater Res B Appl Biomater. 2005;72:373-378.
2. Baleani M, Persson C, Zolezzi C, Andollina A, Borelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty. 2008;23:1232-1238.
3. Barrack RL, Engh G, Rorabeck C, Sawhney J, Woolfrey M. Patient satisfaction and outcome after septic versus aseptic revision total knee arthroplasty. J Arthroplasty. 2000;15:990-993.
4. Bengtson S, Knutson K. The infected knee arthroplasty: a 6-year follow-up of 357 cases. Acta Orthop Scand. 1991;62:301-311.
5. Bertazonni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53:329-334. (Pubitemid 38239970)
6. Buechel FF, Femino FP, D'Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am J Orthop (Belle Mead NJ). 2004;33:190-198; discussion 198.
7. Calton TF, Fehring TK, Griffin WL. Bone loss associated with the use of spacer blocks in infected total knee arthroplasty. Clin Orthop Relat Res. 1997;345:148-154. (Pubitemid 28007497)
8. Cameron HU, Hu C, Vyamont D. Hinge total knee replacement revisited. Can J Surg. 1997;40:278-283. (Pubitemid 27374766)
9. Cierny G 3rd, DiPasquale D. Periprosthetic total joint infections: staging, treatment, and outcomes. Clin Orthop Relat Res. 2002;403:23-28. (Pubitemid 35168351)
10. Cordero-Ampuero J, Esteban J, Garcia-Rey E. Results after late polymicrobial, gram-negative, and methicillin-resistant infections in knee arthroplasty. Clin Orthop Relat Res. 2010;468:1229-1236.
11. Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7-11. (Pubitemid 41099059)
12. Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89:871-882. (Pubitemid 46564296)
13. Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br. 1998;80:63-69.
14. Ensing GT, van Horn JR, van der Mei HC, Busscher HJ, Neut D. Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res. 2008;466:1492-1498.
15. Fehring TK, Griffin WL. Revision of failed cementless total knee implants with cement. Clin Orthop Relat Res. 1998;356:34-38. (Pubitemid 29019469)
16. Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus static spacers in revision total knee arthroplasty for sepsis: The Ranawat Award. Clin Orthop Relat Res. 2000;380:9-16.
17. Fink B, Grossmann A, Fuerst M, Schäfer P, Frommelt L. Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res. 2009;467:1848-1858.
18. Fink B, Makowiak C, Fuerst M, Berger I, Schäfer P, Frommelt L. The value of synovial biopsy, joint aspiration, and C-reactive protein in the diagnosis of late peri-prosthetic infection of total knee replacements. J Bone Joint Surg Br. 2008;90:874-878. (Pubitemid 352009773)
19. Fink B, Vogt S, Reinsch M, Büchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res. 2011;469:3141-3147.
20. Freeman MG, Fehring TK, Odum SM, Fehring K, Griffin WL, Mason JB. Functional advantage of articulating versus static spacers in 2-stage revision for total knee arthroplasty infection. J Arthroplasty. 2007;22:1116-1121. (Pubitemid 350216992)
21. Gallo J, Kolar M, Novotny R, Rihakova P, Ticha V. Pathogenesis of prosthesis-related infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:27-35.
22. Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res. 2009;467:1699-1705.
23. Göksan SB, Freeman MA. One-stage reimplantation for infected total knee arthroplasty. J Bone Joint Surg Br. 1992;74:78-82.
24. Goldman RT, Scuderi GR, Insall JN. 2-stage reimplantation for infected total knee replacement. Clin Orthop Relat Res. 1996;331:118-124. (Pubitemid 26357695)
25. Goldstein WM, Kopplin M, Wall R, Berland K. Temporary articulating methylmethacrylate antibiotic spacer (TAMMAS): a new method of intraoperative manufacturing of a custom articulating spacer. J Bone Joint Surg Am. 2001;83(suppl 2):92-97. (Pubitemid 33070038)
26. Gollwitzer H, Diehl P, Gerdesmeyer L, Mittelmeier W. [Diagnostic strategies in cases of suspected periprosthetic infection of the knee: a review of the literature and current recommendations][in German]. Orthopäde. 2006;35:904, 906-908, 910-916.
27. Guenoun B, Latargez L, Freslon M, Defossez G, Salas N, Gayet LE. Complications following rotating hinge Endo-Modell (Link) knee arthroplasty. Orthop Traumatol Surg Res. 2009;95:529-536.
28. Haddad FS, Masri BA, Campbell D, McGraw RW, Beauchamp CP, Duncan CP. The PROSTALAC functional spacer in two-stage revision for infected knee replacements: prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg Br. 2000;82:807-812. (Pubitemid 30624038)
29. Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35-39. (Pubitemid 39506148)
30. Hanssen AD, Spangehl MJ. Practical applications of antibiotic loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79-85. (Pubitemid 39362835)
31. Hirakawa K, Stulberg BN, Wilde AH, Bauer TW, Secic M. Results of 2-stage reimplantation for infected total knee arthroplasty. J Arthroplasty. 1998;13:22-28. (Pubitemid 28082632)
32. Hofmann AA, Kane KR, Tkach TK, Plaster RL, Camargo MP. Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res. 1995;321:45-54.
33. Hsieh PH, Chang YH, Chen SH, Ueng SW, Shih CH. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res. 2006;24:1615-1621. (Pubitemid 44203293)
34. Huotari K, Lyytikäinen O; Hospital Infection Surveillance Team. Impact of postdischarge surveillance on the rate of surgical site infection after orthopedic surgery. Infect Control Hosp Epidemiol. 2006;27:1324-1329. (Pubitemid 46052279)
35. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;248:13-14. (Pubitemid 20204775)
36. Jämsen E, Stogiannidis I, Malmivaara A, Pajamäki J, Puolakka T, Konttinen YT. Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop. 2009;80:67-77.
37. Jämsen E, Varonen M, Huhtala H, Lehto MU, Lumio J, Konttinen YT, Moilanen T. Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty. 2010;25:87-92.
38. Kordelle J, Frommelt L, Klüber D, Seemann K. [Results of one-stage endoprosthesis revision in periprosthetic infection caused by methicillin-resistant Staphylococcus aureus][in German]. Z Orthop Ihre Grenzgeb. 2000;138:240-244.
39. Kurd MF, Ghanem E, Steinbrecher J, Parvizi J. Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome? Clin Orthop Relat Res. 2010:468:2060-2066.
40. Lu H, Kou B, Lin J. [One-stage reimplantation for the salvage of total knee arthroplasty complicated by infection][in Chinese]. Zhonghua Wai Ke Za Zhi. 1997;35:456-458.
41. Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty. 1998;13:331-338. (Pubitemid 28194004)
42. Meek RM, Masri BA, Dunlop D, Garbuz DS, Greidanus NV, McGraw R, Duncan CP. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am. 2003;85:1888-1892. (Pubitemid 37259722)
43. Neut D, de Groot EP, Kowalski RS, van Horn JR, van der Mei HC, Busscher HJ. Gentamicin-loaded bone cement with clindamycin or fusidic acid added: biofilm formation and antibiotic release. J Biomed Mater Res A. 2005;73:165-170. (Pubitemid 40571538)
44. Neut D, van Horn JR, van Kooten TG, van der Mei HC, Busscher HJ. Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop Relat Res. 2003;413:261-268. (Pubitemid 38063320)
45. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001;392:15-23. (Pubitemid 33054925)
46. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty. 1996;11:939-944.
47. Peters G, Herrmann M, von Eiff C. The changing pattern of coagulase-negative staphylococci as infectious pathogens. Curr Opin Infect Dis. 1995;8(suppl):S12-S19.
48. Phillips JE, Crane TP, Noy M, Elliot TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006;88:943-948. (Pubitemid 44057185)
49. Pour AE, Parvizi J, Slenker N, Purtill JJ, Sharkey PF. Rotating hinged total knee replacement: use with caution. J Bone Joint Surg Am. 2007;89:1735-1741. (Pubitemid 47229880)
50. Saleh KJ, Rand JA, McQueen DA. Current status of revision total knee arthroplasty: how do we assess results? J Bone Joint Surg Am. 2003;85(suppl 1):18-20. (Pubitemid 36538733)
51. Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis. 2008;47:1403-1409.
52. Scuderi GR, Insall JN, Windsor RE, Moran MC. Survivorship of cemented knee replacements. J Bone Joint Surg Br. 1989;71:798-803. (Pubitemid 19282571)
53. Simpson PM, Dall GF, Breusch SJ, Heisel C. [In vitro elution and mechanical properties of antibiotic-loaded SmartSet HV and Palacos R acrylic bone cements][in German]. Orthopäde. 2005;34:1255-1262.
54. Sofer D, Regenbrecht B, Pfeil J. [Early results of one-stage septic revision arthroplasties with antibiotic-laden cement: a clinical and statistical analysis][in German]. Orthopäde. 2005;34:592-602.
55. Steinbrink K, Frommelt L. [Treatment of periprosthetic infection of the hip using one-stage exchange surgery][in German]. Orthopäde. 1995;24:335-343.
56. Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90:145-148. (Pubitemid 351303337)
57. von Foerster G, Klüber D, Käbler U. [Mid- to long-term results after treatment of 118 cases of periprosthetic infections after knee joint replacement using one-stage exchange surgery][in German]. Orthopäde. 1991;20:244-252.
58. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537-1541.